Literature DB >> 12506328

[Effect of a proteinase-activated receptor-2 (PAR-2) agonist on tryptase release from human mast cells].

Shao-Heng He1, Hua Xie, Yong-Song He.   

Abstract

Proteinase-activated receptor-2 (PAR-2) expression has been observed on numerous cell types. However, little is known about the functional expression of PAR-2 in human mast cells. In the current study, the actions of a PAR-2 agonist trans-cinnamoyl-Leu-Ile-Gly-Arg-Leu-Orn-amide (tc-LIGRLO) on tryptase release from dispersed human colonic mast cells were examined. The results showed that tc-LIGRLO was able to induce a fold increase in tryptase release over the basal level following a 15 min incubation of colonic mast cells, whereas tc-OLRGIL did not have any effect on tryptase release. The potency of tc-LIGRLO appeared greater than that of anti-IgE and calcium ionophore A23187 (CI) in induction of tryptase release. Extending the incubation time to 30 min had no significant effect on the actions of tc-LIGRLO or anti-IgE. In the time course study, it was observed that the tryptase release from mast cells induced by tc-LIGRLO started at 1 min and peaked at 3 min following incubation. The above-mentioned results indicate that tc-LIGRLO is a potent stimulus of tryptase release from human mast cells, which strongly suggests that PAR-2s are expressed in human mast cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12506328

Source DB:  PubMed          Journal:  Sheng Li Xue Bao        ISSN: 0371-0874


  2 in total

1.  Induction of tryptase and histamine release from human colon mast cells by IgE dependent or independent mechanisms.

Authors:  Shao-Heng He; Hua Xie; Yong-Song He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

Review 2.  Mechanisms for amplified mediator release from colonic mast cells: implications for intestinal inflammatory diseases.

Authors:  Kim E Barrett
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.